Portal vein reconstruction in adult living donor liver transplantation using cryopreserved vein grafts

Yasuhiko Sugawara, Masatoshi Makuuchi, Sumihito Tamura, Yuichi Matsui, Junichi Kaneko, Kiyoshi Hasegawa, Hiroshi Imamura, Norihiro Kokudo, Noboru Motomura, Shinichi Takamoto – 24 May 2006 – No data are available for the management of venous jump or interposition conduits for portal vein (PV) reconstruction in adult living donor liver transplantation (LDLT). The feasibility of using cryopreserved vein grafts as PV conduits was examined. Cryopreserved vein (n = 23) was used as a patch, interposition, or jump graft.

Saying “yes” to obese living liver donors: Short‐term intensive treatment for donors with hepatic steatosis in living‐donor liver transplantation. Nakamuta M, Morizono S, Soejiima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Transplantation 2005;80:608–6

Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe

Shin Hwang, Sung‐Gyu Lee, Young‐Joo Lee, Kyu‐Bo Sung, Kwang‐Min Park, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Gyu‐Sam Hwang, Kyung‐Mo Kim, Tae‐Yong Ha, Dong‐Sik Kim, Jae‐Pil Jung, Gi‐Won Song – 23 May 2006 – Serious complications have occurred in a considerable proportion of living donors of liver transplants, but data from a single high‐volume center has rarely been available. We analyzed the medical records of donors and recipients of the first 1,000 living donor liver transplants, performed at Asan Medical Center from December 1994 to June 2005, with a focus on donor safety.

Living donor liver transplantation as a second‐line therapeutic strategy for patients with hepatocellular carcinoma

Yasutsugu Takada, Mikiko Ueda, Takashi Ito, Seisuke Sakamoto, Hironori Haga, Yoji Maetani, Kohei Ogawa, Mureo Kasahara, Fumitaka Oike, Hiroto Egawa, Koichi Tanaka – 23 May 2006 – Living donor liver transplantation (LDLT) has evolved to represent an important surgical strategy for patients with hepatocellular carcinoma (HCC). However, due to disadvantages, including donor risks and higher rates of perioperative complications, LDLT has been considered as a second‐line treatment in Japan.

Biliary strictures in living donor liver transplantation: Incidence, management, and technical evolution

Yuji Soejima, Akinobu Taketomi, Tomoharu Yoshizumi, Hideaki Uchiyama, Noboru Harada, Hideki Ijichi, Yusuke Yonemura, Tetsuo Ikeda, Mitsuo Shimada, Yoshihiko Maehara – 23 May 2006 – Biliary complications, biliary strictures (BS) in particular, continue to be a significant cause of morbidity after LDLT despite technical refinement. In this study, we assessed the incidence of BS and their management in living donor liver transplantation (LDLT) with special reference to the type of biliary reconstruction.

Subscribe to